Clinical trials: Chronic Lymphoproliferative Diseases (CLPD)
Chronic Lymphoproliferative Disease
Cell Population Data in CLPD and Viral Disease
Hematological malignancies typically arise from two major blood cell lineages: lymphoid and myeloid cells . Hematological malignancies are the fourth most frequently diagnosed cancer around the world .
- Trial name
- NCT06893640
- Volunteers
- 177 people, healthy volunteers welcome
- Sponsor
- Assiut University
Chronic Lymphoproliferative Diseases (CLPD)
BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.
Multi-site, prospective performance study to determine equivalency between the investigational CLPD Full Panel on the FACSLyric system versus the final clinical diagnosis.
- Trial name
- NCT05557422
- Testing
- BD OneFlow LST, and B-CLPD T1 to T4 Assays
- Where
- 6 sites in United States, Netherlands and 3 more
- Volunteers
- 322 people
- Sponsor
- Becton, Dickinson and Company
Chronic Lymphoproliferative Diseases (CLPD)
Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer
Multi-site, prospective performance study to determine equivalency between the investigational CLPD Limited Panel on the FACSLyric system versus the final clinical diagnosis.
- Trial name
- NCT05032313
- Testing
- IUO CLPD Limited Panel
- Where
- 6 sites in United States, Portugal and 3 more
- Volunteers
- 371 people
- Sponsor
- Becton, Dickinson and Company